
ESPR
Esperion Therapeutics, Inc.NASDAQHealthcare$2.61+0.00%ClosedMarket Cap: $542.6M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
6
Sales
4
Buy/Sell Ratio
1.50
Total Bought
$0.00
Total Sold
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Mar 18 | Looker Benjamin | officer: Chief Legal Officer | Sell | 5,708 | $2.70 | 679,348 |
| Wed Mar 18 | Koenig Sheldon L. | director, officer: President and CEO | Sell | 25,578 | $2.72 | 2,172,699 |
| Wed Mar 18 | Halladay Benjamin | officer: Chief Financial Officer | Sell | 6,424 | $2.71 | 713,602 |
| Mon Mar 16 | Looker Benjamin | officer: Chief Legal Officer | Sell | 300,840 | $0.00 | 685,056 |
| Mon Mar 16 | Looker Benjamin | officer: Chief Legal Officer | Sell | 269,230 | $2.44 | 269,230 |
| Mon Mar 16 | Koenig Sheldon L. | director, officer: President and CEO | Sell | 723,760 | $0.00 | 2,198,277 |
| Mon Mar 16 | Koenig Sheldon L. | director, officer: President and CEO | Sell | 647,460 | $2.44 | 647,460 |
| Mon Mar 16 | Halladay Benjamin | officer: Chief Financial Officer | Sell | 247,430 | $0.00 | 720,026 |
| Mon Mar 16 | Halladay Benjamin | officer: Chief Financial Officer | Sell | 221,270 | $2.44 | 221,270 |
| Wed Jan 21 | Looker Benjamin | officer: General Counsel | Sell | 1,689 | $2.88 | 384,216 |